Non-occupational post exposure prophylaxis as a biobehavioral HIV-prevention intervention

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 20, Issue 3, 2008, Pages 376-381

  Shoptaw, S ^a,b   Rotheram Fuller, E ^a   Landovitz, R J ^c   Wang, J ^a   Moe, A ^c   Kanouse, D E ^d   Reback, C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b FRIENDS RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d RAND CORPORATION   (United States)

Author keywords

AIDS; Feasibility; HIV; Non occupational exposure; Post exposure Prophylaxis; Prevention

Indexed keywords

LAMIVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONDOM; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; TREATMENT PLANNING;

ADULT; ANTI-HIV AGENTS; ATTITUDE TO HEALTH; DRUG COMBINATIONS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LAMIVUDINE; MALE; RISK-TAKING; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 41349097959     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120701660353     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention (2005a). HIV/AIDS Surveillance Report (Vol. 17, p. 31). Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention.
2. Centers for Disease Control and Prevention (2005b). Updated US Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for Post-exposure Prophylaxis. Morbidity and Mortality Weekly Report, 54(No. RR-9), 1-17.
3. Centers for Disease Control and Prevention (2005c). Antitiretroviral postexposure prophylaxis after sexual, injection-drug use or other non-occupational exposure to HIV in the US: Recommendations from the US Department of Health and Human Services. Morbidity and Mortality Weekly Report; 54(No. RR-2): 1-20.
4. Cohen, DA., Wu, S.Y., & Farley, T.A. (2004). Comparing the cost-effectiveness of HIV prevention interventions. Journal of Acquired Immune Deficiency Syndrome, 37, 1404-1414.
5. Easterbrook, P., & Ippolito, G. (1997). Prophylaxis after occupational exposure to HIV. British Medical Journal, 315, 557-558.
6. Kahn, J.O., Martin, J.N., Roland, M.E., Bamberger, J.D., Chesney, M., Chambers, D., et al. (2001). Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP Study. Journal of Infectious Diseases, 183, 707-714.
7. Los Angeles County Department of Health Services (2006). HIV Epidemiology Program HIV/AIDS Surveillance Summary, page 10. Retrieved December 18 2006, from http://lapublichealth.org/wwwfiles/ph/hae/hiv/ Semiannual_Surveillance_Summary_January2006.pdf
8. Martin, J.N., Roland, M.E., Neilands, T.B., Krone, M.R, Bamberger, J.D., Kohn, R.P., et al. (2004). Use of post-exposure prophylaxis against HIV infection following sexual exposure does not lead to increases in high-risk behavior. AIDS, 18, 787-792.
9. National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group (1998). The NIMH Multisite HIV Prevention Trial: Reducing HIV sexual risk behavior. Science, 280, 1889-1894.
10. Roland, M.E., Neilands, T.B., Kron, M.R, Katz, M.H, Franses, K., Grant, R.M., et al. (2005). Seroconversion following non-occupational postexposure prophylaxis against HIV. Clinical Infectious Diseases, 41, 1507-1513.
11. Russi, M. (2002). HIV and AIDS in the workplace. Journal of Occupational and Environmental Medicine, 44, 495-502.
12. Schechter, M., Mendelsohn, A.B., Moreira, R.L., Moulton, L.H., & Harrison, L.H. (2004). Behavioral impact, acceptability, and HIV incidence among homosexual men with access to post-exposure chemoprophylaxis for HIV. Journal of Acquired Immune Deficiency Syndrome, 35, 519-525.